BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe Spring® 2015 Press Releases

News for BIO-Europe Spring® 2015 will be available soon

BIO-Europe Spring 2014 press releases

March 20, 2014BIO-Europe Spring® 2014 partnering event brought over 2,000 life science executives to Turin, Italy last week The eighth annual BIO-Europe Spring® international partnering conference took place last week, March 10–12 in Turin, Italy. The event, held at the Oval Lingotto conference center, welcomed more than 2,000 participants representing over 1,200 companies from 42 countries vying for 2,115 licensing opportunities. More than 10,700 one-to-one meetings took place at the event b...  more ►

March 3, 2014BIO-Europe Spring® 2014 kicks off next week in Turin, ItalyEvent is gathering of life science industry leaders
The eighth annual BIO-Europe Spring® conference kicks off in one week on March 10–12 in Turin, Italy. The event is expected to draw over 2,000 high-level executives from pharma, biotech, venture capital firms, and service companies who will be coming to Turin to engage in one-to-one partnering meetings with innovative biotech startups. Delegates are expected to engage in...  more ►

February 25, 2014"Competition fierce" as big pharma moves to early stage deals The focus for Roche meetings at BIO-Europe Spring® breaks out roughly with a third devoted to ongoing relationships, another third focused on active negotiation and one third opportunistic. "We have to spend more time filtering through that last third, but I can tell you we have found programs over the past year that quickly moved to a high priority status."
more ►

February 12, 2014BIO-Europe Spring® program in Turin will engage executives in provocative topics facing drug development industry Life science executives are quickly filling up the program at the eighth annual BIO-Europe Spring® conference to be held March 10–12, 2014 in Turin, Italy. The international bio-pharma partnering event annually attracts top international executives from established and emerging biotech companies; pharmaceutical companies; private investors including venture capital and priva...  more ►

join the conversation ►

January 29, 2014Spotlight on Turin Business Facts A BUSINESS HUB: According to 2012 data provided by the Register of Enterprises, held by the Torino Chamber of Commerce, the number of businesses based in the Torino Province equals 237,000. LIFE SCIENCES: The Turin Life Science sector comprises medium and large companies operating in the following fields: Medical, Electromedical, and Diagnostic instrumentation; Orthopedic pros...  more ►

join the conversation ►

December 12, 2013Turin, Italy welcomes the 2014 edition of BIO-Europe Spring®Pharmaceutical dealmakers converge upon Italian innovation hub
The eighth annual BIO-Europe Spring® conference will be held March 10–12, 2014 in Turin, Italy at the OVAL Lingotto conference center. The event is recognized by life science insiders as the place for established biotech and early-stage companies to meet and form partnerships with venture capitalists and business development executives from big pharma companies. Investor...  more ►

join the conversation ►


partnering360® Blog

September 30, 2014 What does Sanofi look for in innovation? At BioPharm America™, John Carroll, Editor-in-Chief of FierceBiotech, sat down with Gary Nabel, CSO of Sanofi to discuss what they look for when investing in technologies. Sanofi is particularly interested in transformative innovation which brings a new medical concept to a patient and solves... more ►

September 29, 2014 Twenty-five tips on giving the “Perfect Pitch” from VCs at BioPharm America™ Doug  MacDougall, President of MacDougall Biomedical Communications, moderated “The perfect pitch: Do you have what it takes to win over investors?” workshop at BioPharm America™ on Monday morning to a packed room of executives eager to give their “elevator pitch” to a panel of VCs. The... more ►

September 25, 2014 BioPharm America™: Eight Facts from Day 3 On our third and final day of BioPharm America™ highlighted academic innovators and shared why being a part of an innovation hub – like here in Boston – is an important part of scientific innovation for the medical community. Johannes Fruehauf, the Founder and President of LabCentral... more ►

September 25, 2014 Web Seminar: How to Improve your Partnering Effectiveness BioPharm America™ has come to a close.  So how can you connect and network with those you met onsite?  Or if you were unable to join us in Boston, how can you connect and leverage potential partnerships?  on October 15, the partnering360® team will host a web seminar to share with you how you... more ►

September 24, 2014 BioPharm America™ Day 2: What is Big Pharma looking for in partners? Today at BioPharma America™, companies took the spotlight sharing many of the reasons that Pharma is accelerating and creating and innovating in the drug market. What do the big Pharma companies have to offer?  What are they looking for? Merck believes that great drugs build great franchises... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe Spring EBD Group BIO BIO-Europe Spring